Stephen Ansell, MD, PhDEnriched profile
Professor of Medicine, Mayo Clinic College of Medicine and Science; Chair, Division of Hematology; Chair, Lymphoma Disease Group; Dorotha W. and Grant L. Sundquist Professor in Hematologic Malignancies Research; Consultant, Division of Hematology, Mayo Clinic · Mayo Clinic
Overview
Updated 14 Jul 2026
Stephen Ansell, M.D., is Professor of Medicine, Mayo Clinic College of Medicine and Science. The public record shows 1,478 publications with 52,585 citations (h-index 113), centered on Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 2 companies, 4 NIH-funded awards (2002–2024).
- Most recent indexed publication: 2026 · British journal of haematology
- Top research focus: Lymphoma Diagnosis and Treatment
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 82 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 541.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Mayo Clinic
InvestigatorPhase 2Active, not recruitingNCT05507541 - Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Sponsor: Mayo Clinic
InvestigatorPhase 2TerminatedNCT03075553 - Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2Active, not recruitingNCT03038672
Industry payments
Updated 14 Jul 2026
2 companies reported payments to CMS in program years 2022–2024. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20245 payments$10,114openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20232 payments
- AstraZeneca Pharmaceuticals LPProgram year20224 payments
NIH funding
Updated 14 Jul 2026
4 NIH research awards on record, funded 2002–2024 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- No association of prior administration of selected vaccines with lymphoma prognosis.
Cancer epidemiology, biomarkers & prevention
2026 - High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.
American journal of hematology
2026
Most-cited worksby citation count (OpenAlex)
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD (M.B., Ch.B.)
University of Pretoria, South Africa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aol.amegroups.org ↗ - PhD
University of Pretoria, South Africa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aol.amegroups.org ↗ - Board Certified
American Board of Internal Medicine, Hematology and Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership rolesjournal and society appointments
- Chair
Division of Hematology, Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗ - Chair
Lymphoma Disease/Group, Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lymphoma.org ↗ - Co-leader
Hematological Malignancies Program, Mayo Clinic Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Awards & honorshonors on the public record
- 2022 LLS Excellence in Scientific Service Award (Leukemia & Lymphoma Society)
inaugural presentation of this award, one of six scientists honored with 2022 Achievement Awards
2022 - Inaugural recipient
Dorotha W. and Grant L. Sundquist Professorship in Hematologic Malignancies Research, Mayo Clinic
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗ - 2021 Ernest Beutler Lecture and Prize (American Society of Hematology)
translational/clinical co-recipient, shared with basic-science co-recipient Margaret Shipp, MD (Dana-Farber/Harvard) …
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
Secondary affiliationsappointments beyond the home institution
- Scientific Advisory Board member
Light Chain Bioscience (NovImmune SA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lightchainbio.com ↗ - Scientific Advisor
Affimed
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
Media & interviewspress, podcasts and appearances
- Guest
Mayo Clinic Talks podcast, episode 'Hodgkin's Lymphoma'
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Guest
Mayo Clinic Talks podcast, episode 'Non-Hodgkin's Lymphoma'
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Video interview subject
VJHemOnc, discusses B-cell malignancy biology and the tumor microenvironment
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/stephen-ansell-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/mayo-clinic_the-american-society-of-hematology-recognizes-activity-6882437883878232064-51bN
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
mayoclinic.elsevierpure.com/en/persons/stephen-maxted-ansell
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.elsevierpure.com ↗ - Other
mayoclinic.org/biographies/ansell-stephen-m-m-d-ph-d/bio-20053059
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ayalew Tefferi, MD
Mayo Clinic
- 2,093
- publications
- 154
- h-index
- 7
- trials
Angela Dispenzieri, MD
Mayo Clinic
- 2,490
- publications
- 146
- h-index
- 13
- trials
Shaji Kumar, MD
Mayo Clinic
- 2,207
- publications
- 137
- h-index
- 39
- trials
Morie Gertz, MD
Mayo Clinic
- 1,944
- publications
- 140
- h-index
- 7
- trials